Cited by 15Bone Metabolism and DiseasesOsteoarthritis Treatment and MechanismsRheumatoid Arthritis Research and Therapies

Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE2 production in chondrocytes

Open access
Honda, Kazuhiro·2011·Journal of Oral Science

Abstract

This study examined how interleukin-6 (IL-6) and soluble IL-6 receptor (sIL-6r) influence osteoclastic differentiation through the function of chondrocytes. Chondrocytes were cultured with or without IL-6 and/or sIL-6r in the presence or absence of NS398, a specific inhibitor of cyclooxygenase (COX)-2, for up to 28 days. Chondrocytes were also cultured with or without IL-6 and sIL-6r for 28 days, and the conditioned medium from cells cultured without IL-6 and sIL-6r was used to induce differentiation of RAW264.7 cells into osteoclast precursors. Osteoclastic differentiation was assessed by tartrate-resistant acid phosphatase (TRAP) staining. Expression of osteoprotegerin (OPG), receptor activator of NF-κB ligand (RANKL), COX-2, and prostaglandin E(2) (PGE(2)) increased in cells exposed to IL-6 and sIL-6r, whereas expression of macrophage colony-stimulating factor (M-CSF) and bone resorption-related enzymes decreased. NS398 blocked the stimulatory/suppressive effects of IL-6 and sIL-6r on the expression of OPG, RANKL, and M-CSF. Fewer TRAP-positive multinucleated cells were detected after treatment with conditioned medium from IL-6- and sIL-6r-treated chondrocytes than after treatment with conditioned medium from untreated chondrocytes. These results suggest that IL-6 and sIL-6r interfere with osteoclast function through the involvement of chondrocytes. Specifically, they appear to suppress the differentiation of osteoclast precursors into osteoclasts by inducing chondrocytic PGE(2) production, which, in turn, increases OPG secretion and decreases M-CSF secretion by chondrocytes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2334/josnusd.53.87

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-6 and its soluble receptor sIL-6r suppress differentiation of osteoclasts by inducing chondrocytic PGE2.

    “He found that IL-6 and IL-6r suppressed the differentiation of osteoclasts by inducing chondrocytic PGE2 [44].”

    From Osteoclasts and Microgravity (2020) · cites this paper as [44]

    The Discussion concludes that IL-6 and sIL-6r may suppress osteoclast differentiation through PGE2 production in chondrocytes. The citing sentence presents this proposed causal mechanism as an established finding, whereas the paper frames it as a conclusion suggested by its results. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 1

  1. Watanabe Y, Namba A, Aida Y, Honda K, Tanaka H, Suzuki N, Matsumura H, Maeno M (2010) IL- 1β suppresses the formation of osteoclasts by increasing OPG production via an autocrine m e c h a n i s m i nvo l v i n g c e l e c o x i b -r e l a t e d prostaglandins in chondrocytes. Mediators Inflamm 2009, doi:10.1155/2009/308596. · DOI · Paper page

Cited by

Sorted by citations

Authors
Honda, K.
Affiliations
Nihon University (JP)
Corresponding author
Honda, Kazuhiro
Venue
Journal of Oral Science
Published
2011
Volume
53
Issue
1
Pages
87-96
ISSN
  • 1343-4934 (ISSN-L)
  • 1880-4926
OpenAlex
W2131773419
Cited by
15
References
0
Citations by year
2023: 1 · 2022: 2 · 2020: 1 · 2018: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 4
FWCI
0.91
Type
journal article
Language
en
Open access
Locations
  • Journal of Oral Science (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Nihon University
  • School of Dentistry, Nihon University
  • Promotion and Mutual Aid Corporation for Private Schools of Japan
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
interleukin-6, soluble IL-6 receptor, osteoclastogenesis, chondrocytes, prostaglandin E2, cyclooxygenase-2, osteoprotegerin, RANKL, macrophage colony-stimulating factor, bone resorption, osteoclast precursors, TRAP staining
MeSH terms
Interleukin-6 Inhibitors, Anti-Inflammatory Agents, Non-Steroidal, Bone Resorption, Cell Differentiation, Cells, Cultured, Humans, Nitrobenzenes, Osteoclasts, Prostaglandin-Endoperoxide Synthases, Sulfonamides, Dinoprostone, Interleukin-6, Gene Expression, Macrophage Colony-Stimulating Factor, Chondrocytes, Receptors, Interleukin-6, Matrix Metalloproteinase 9, Carbonic Anhydrase II, Cyclooxygenase 2, Osteoprotegerin, RANK Ligand, Cathepsin K

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review